Healthcare provider profile · identity verified

Mark Andrew Scott, M.D.

Family Practice · GERMANTOWN, TN · NPI 1194088054

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	611	189
Amlodipine Besylate	Amlodipine Besylate	523	168
Levothyroxine Sodium	Levothyroxine Sodium	302	82
Losartan Potassium	Losartan Potassium	300	92
Hydrochlorothiazide	Hydrochlorothiazide	225	67
Metformin Hcl	Metformin Hcl	209	70
Omeprazole	Omeprazole	180	52
Pantoprazole Sodium	Pantoprazole Sodium	175	59
Lisinopril	Lisinopril	165	48
Gabapentin	Gabapentin	163	49
Rosuvastatin Calcium	Rosuvastatin Calcium	158	50
Tamsulosin Hcl	Tamsulosin Hcl	132	41
Allopurinol	Allopurinol	119	34
Furosemide	Furosemide	115	49
Famotidine	Famotidine	111	46
Trazodone Hcl	Trazodone Hcl	111	35
Metoprolol Succinate	Metoprolol Succinate	110	32
Diclofenac Sodium	Diclofenac Sodium	107	42
Meloxicam	Meloxicam	103	27
Sertraline Hcl	Sertraline Hcl	103	38
Azelastine Hcl	Azelastine Hcl	96	66
Potassium Chloride	Potassium Chloride	89	35
Carvedilol	Carvedilol	82	29
Simvastatin	Simvastatin	82	25
Albuterol Sulfate Hfa	Albuterol Sulfate	76	32
Alprazolam	Alprazolam	75	12
Metoprolol Tartrate	Metoprolol Tartrate	75	26
Tizanidine Hcl	Tizanidine Hcl	71	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	71	22
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	66	36
Doxycycline Hyclate	Doxycycline Hyclate	62	52
Fluticasone Propionate	Fluticasone Propionate	62	33
Spironolactone	Spironolactone	61	20
Montelukast Sodium	Montelukast Sodium	60	19
Chlorthalidone	Chlorthalidone	59	23
Clopidogrel	Clopidogrel Bisulfate	58	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	20
Escitalopram Oxalate	Escitalopram Oxalate	56	18
Glipizide	Glipizide	54	18
Alendronate Sodium	Alendronate Sodium	53	18
Zolpidem Tartrate	Zolpidem Tartrate	52	suppressed
Tradjenta	Linagliptin	51	13
Metformin Hcl Er	Metformin Hcl	50	18
Pravastatin Sodium	Pravastatin Sodium	50	14
Atenolol	Atenolol	45	15
Ezetimibe	Ezetimibe	45	13
Fluconazole	Fluconazole	45	19
Eliquis	Apixaban	44	11
Lorazepam	Lorazepam	44	suppressed
Pregabalin	Pregabalin	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	12
Colchicine	Colchicine	37	12
Hydroxyzine Hcl	Hydroxyzine Hcl	37	12
Finasteride	Finasteride	36	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	32
Januvia	Sitagliptin Phosphate	33	suppressed
Azithromycin	Azithromycin	31	29
Cephalexin	Cephalexin	31	28
Diazepam	Diazepam	31	suppressed
Jardiance	Empagliflozin	31	12
Meclizine Hcl	Meclizine Hcl	31	15
Synthroid	Levothyroxine Sodium	31	11
Glimepiride	Glimepiride	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	12
Ozempic	Semaglutide	29	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	11
Nifedipine Er	Nifedipine	27	suppressed
Methylprednisolone	Methylprednisolone	26	26
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	15
Donepezil Hcl	Donepezil Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	24
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Mupirocin	Mupirocin	23	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Torsemide	Torsemide	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Prednisone	Prednisone	17	12
Irbesartan	Irbesartan	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Trandolapril	Trandolapril	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Linzess	Linaclotide	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Lovastatin	Lovastatin	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error